Teva CEO on Shares Trading Directly on the NYSE
Teva Pharmaceuticals President & CEO Richard Francis, discusses why Teva chose to make the change now and what will be different for investors as the shares move from ADRs to direct NYSE trading. He speaks with Romaine Bostick & Isabelle Lee on "The Close." (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
